Allison Hagerman
CIK: 0002103583
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ONCY
ONCOLYTICS BIOTECH INC
Officer
Discretionary Trading P&L
Holdings
About Hagerman Allison
Hagerman Allison (SEC CIK 0002103583) files insider reports with the SEC as Chief Technology Officer of ONCOLYTICS BIOTECH INC (ONCY).
Signal8 holds 3 ownership filings by Hagerman Allison (1 Form 3, 2 Form 4), filed between Jan 2, 2026 and Jun 3, 2026. Those filings report 2 transactions, from Feb 12, 2026 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hagerman Allison's filings is in SAN DIEGO, CA.
Recent filings by Hagerman Allison
Other insiders filing for ONCOLYTICS BIOTECH INC (ONCY)
- McAdory John Bearden, Chief Operating Officer
- Pisano Wayne, Director
- RIGBY JONATHAN, Director
- Holtham Angela, Director
- Parsons James T., Director
- Look Kirk, Chief Financial Officer